Title
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans
Date Issued
01 April 2008
Access level
metadata only access
Resource Type
journal article
Author(s)
Kelly J.
Kelley J.
Kaufman K.
Kilpatrick J.
Bruner G.
Merrill J.
James J.
Frank S.
Reams E.
Brown E.
Gibson A.
Marion M.
Langefeld C.
Li Q.
Karp D.
Wakeland E.
Petri M.
Ramsey-Goldman R.
Reveille J.
Vilá L.
Kimberly R.
Harley J.
Edberg J.
Heersink School of Medicine
Abstract
Increased expression of interferon (IFN)-inducible genes is implicated in the pathogenesis of systemic lupus erythematosus (SLE). One transcription factor responsible for regulating IFN, interferon regulatory factor-5 (IRF5), has been associated with SLE in genetic studies of Asian, Caucasian and Hispanic populations. We genotyped up to seven polymorphic loci in or near IRF5 in a total of 4870 African-American and Caucasian subjects (1829 SLE sporadic cases and 3041 controls) from two independent studies. Population-based case-control comparisons were performed using the Pearson's χ2-test statistics and haplotypes were inferred using HaploView. We observed significant novel associations with the IRF5 variants rs2004640 and rs3807306 in African Americans and replicated previously reported associations in Caucasians. While we identified risk haplotypes, the majority of haplotypic effects were accounted for by one SNP (rs3807306) in conditional analyses. We conclude that genetic variants of IRF5 associate with SLE in multiple populations, providing evidence that IRF5 is likely to be a crucial component in SLE pathogenesis among multiple ethnic groups.
Start page
187
End page
194
Volume
9
Issue
3
Language
English
OCDE Knowledge area
Inmunología
Genética, Herencia
Reumatología
Scopus EID
2-s2.0-42549152933
PubMed ID
Source
Genes and Immunity
Resource of which it is part
Genes and Immunity
ISSN of the container
14664879
DOI of the container
10.1038/gene.2008.4
Sponsor(s)
We thank Debbie McDuffie, Lifeng Zhang and Julius Tate (UAB) for technical assistance. We also acknowledge our study participants without whom this study would not have been possible. This work was supported by the NIH (AI24717, AI31584, AI53747, AI62629, AR12253, AR33062, AR42460, AR42476, AR43727, DE15223, P01-AR49084, K24-AR02138, MO1-RR00032, MO1-RR00048, M01-RR00052, P60-AR48098, RR15577, RR20143 and T32-AR07450), the Alliance for Lupus Research, the American College of Rheumatology Research and Education Foundation, Mary Kirland Scholar, Program for Research Experience in Pathology (UAB), University of Alabama Health Sciences Foundation, and the US Department of Veterans Affairs.
Sources of information:
Directorio de Producción Científica
Scopus